The present invention relates to a system and method for optimizing Kegel exercises and more particularly, to a system and method for optimizing Kegel exercises using a device that measures a patient's performance of Kegel exercises and provides feedback to the patient.
Urinary incontinence is a prevalent condition in women that is associated with weakened pelvic floor muscles. Many common factors contribute to the weakening of the pelvic floor muscles in women such as pregnancy, childbirth, surgery, aging and weight gain. As the pelvic floor muscles weaken, women begin to suffer from urinary incontinence and experience related symptoms such as involuntarily leaking urine while sneezing, laughing or coughing. These symptoms are often uncomfortable, embarrassing and present personal hygiene issues for many women.
Various methods have been proposed to improve the strength and tone of the pelvic floor muscles. Dr. Arnold Kegel described pelvic floor exercises as a treatment option in urinary incontinence and invented a set of exercises, known as Kegel exercises to strengthen and support the pelvic floor. Kegel exercises are performed by repeatedly contracting and relaxing the pelvic floor muscles for a period of time. The repeated pelvic muscle contractions result in a stronger pelvic floor over time. Proper performance of Kegel exercises can provide for both the prevention and treatment of urinary incontinence, fecal incontinence, pelvic pain, and pelvic-organ prolapse. Proper performance of Kegel exercises can also result in the improvement of sexual experience.
Although Kegel exercises are an effective method to strengthen the pelvic floor, many women find it difficult to perform Kegel exercises correctly. Often women performing Kegel exercises simply do not know whether or not they are contracting the right muscles. Some women simply have problems identifying and contracting the right muscles. Some women may perform Kegel exercises incorrectly without even knowing that they are using the wrong muscles. Currently, there are not systems that measure a patient's performance with Kegel exercises or provide a patient with any feedback on their performance. If Kegel exercises are not done by engaging the right pelvic floor muscles, the patient may not achieve the maximum benefit, or any benefit, from performing the Kegel exercises.
Therefore, it would be advantageous to have a system and a method of optimizing Kegel exercises to achieve the maximum benefit from performing Kegel exercises and to address the above mentioned problems with Kegel exercises.
The present invention contemplates the real-time position and movement tracking described in International Patent Applications PCT/US2010/053712 and PCT/US2013/023806, and the multiple sensor-enable device described in International Patent Application PCT/US2012/066613, which are hereby incorporated in their entirety by reference. In this regard, the real-time position and movement tracking may include sensing the position of the anatomical organ of interest to an anatomical reference point, such as the patient's pubic bone, the coccyx or the vagina, or to an external reference point, such as a target on a patient's garment or in the patient's surroundings. The method may be performed in real-time, for example, during a medical examination, procedure, or surgery. In another embodiment, the method may be performed at multiple time intervals. The multiple time intervals may occur, for example, pre- and post-event, wherein the event may be pregnancy or menopause.
The present invention may also be used to diagnose and treat pelvic organ prolapse (POP). Where the multiple sensor enabled device for vaginal insertion is capable of providing real-time data regarding the patient's physiology, the position and movement of the urethra, and the muscular strength of the patient's vagina and pelvic floor, this information may be used to treat and diagnose POP. The multiple sensor-enabled device may also provide pressure data, which reflects muscular strength, and provides a health care provider a detailed map of where the weakest anatomical points are for purposes of POP diagnosis and treatment. Where vaginal strengthening exercises are inadequate to prevent or relieve UI or POP, a surgeon would be able to use this information to target corrective procedures appropriately.
This invention is for a device for dynamically determining and displaying the position of the anterior wall of the vagina within the set of pelvic organs. It may consist of a set of MEMS accelerometer sensors, the positions of which show the profile of a flexible probe inserted into the vagina. The unique ability to display effects of the contracting pelvic muscles permits the proper training of patients in performing Kegel muscle contractions for prevention or mitigation of pelvic dysfunction including urinary incontinence, fecal incontinence, pelvic pain, and pelvic-organ prolapse. Proper Kegel training may also improve sexual experience. Temperature may be recorded as well.
The system may consist of the vaginal device, a cable from the vaginal device to an electronics box, a BLUETOOTH® wireless connection (a short-range radio wave communication) from the electronics box to a smart device such as an IPHONE®, IPOD®, or IPAD® (or ANDROID®- or WINDOWS®-based or other equivalents) for display and recording of results, with an Internet connection to a web server with a database. The data on this web server may be accessed with the correct authorization by the patient, their healthcare provider, or third party payers.
In addition to the training screens (dynamic-line profile or anatomical animation), the smart-device application may offer the user a history of her performance of up to a specified number of sessions as recorded on the smart device, and access to tour of the application, application settings, answers to Frequently Asked Questions, database web service, and other elements. A session is one set of maneuvers performed by a patient from the time she hits the Training button in the application to the time she hits the Stop button.
To work properly, the vaginal device must be inserted in the correct orientation so the MEMS accelerometers can work correctly. A line may be included on the vaginal device indicating how the device should be inserted. Additionally, the smart-device may display a screen showing the current orientation of the vaginal device and providing guidance of how to change to the proper orientation if the vaginal device is not positioned correctly.
Knowing the position of the vagina allows the healthcare professional to infer the likely position of related pelvic organs including the position of the urethra. As the vagina and the urethra are in close proximity and their relative location can be inferred from one another.
The contracting muscles are located near the entrance to the vagina or the introitus. In addition to the display of profile of the vaginal device, the temperature of the device slightly above the introitus may be displayed. The temperature reflects how hard the muscles are working. In another embodiment, pressure sensors may be included to measure and display the force of the muscle contractions.
The purpose of the device is to provide visual feedback to the patient to show whether the Kegel exercise is being performed correctly, and, if so, how effective the exercise is. With permission of the patient, the data can also be reviewed by healthcare professionals and third-party payers. In some situations, the performance of the patient and/or results (e.g., reduction of stress urinary incontinence) compared to initial performance may be used to assess outcomes and positively influence payments to physicians by third-party payers. It is also possible to have economic incentives for the patient. The display may be one or both indicating the actual movement and displaying the associated score.
In alternative embodiments, the feedback can be auditory in the form of voice, auditory in the form of a tone changing in magnitude, frequency, or both, or vibration changing in magnitude, frequency, or both. Voice feedback can include coaching, encouraging the patient to try harder during the performance of a Kegel exercise.
As the Kegel exercise is performed, the vaginal device lifts up and a line on the screen rotates from right to left indicated movement towards the front of the patient. The greater the lift, the more effective is the Kegel. The resultant score can be displayed in addition to or instead of the line position. Another display mode may be the relative position of the pelvic organs as an anatomical animated diagram. If the patient is performing the Kegel exercise incorrectly, the displayed line on the screen from the beginning of the exercise may rotate clockwise into a designated area on the screen as the patient bears down as she would do in a bowel movement. One of the key uses of the invention is to train the patient that such bearing down is incorrect if one wants to do a Kegel exercise. The line moving into the designated area, however, is not necessarily bad. When treating pelvic pain due to muscular contracture, a down movement of the device with a resultant clockwise rotation of the displayed line into the designated area on the screen would mean pelvic relaxation and its consequent descent.
The units of scoring may be Kegel power (kp). While in one embodiment scores are in the range of 0 to 100, other ranges can be used as well. At the beginning of their training, the muscles of many patients are weak. To provide encouragement, the application provides a zoom function so full deflection of the line is approximately 30 or 60 instead of 100. Therefore the line will move more providing positive feedback, although the score displayed is the same for any zoom level. Data from the Kegel training sessions are recorded on the smart device and data from the latest specific number (for example, 300) of sessions can be displayed on a history screen. In addition, session results are sent to the database on the web server. The information recorded and communicated can be just the highest score information including the time interval that the maximum level was held. Alternatively, the actual profile of the vaginal device as it changes can be transmitted. In addition, the temperature and pressure results, if any, are recorded, along with the start time and length of the session. Diary information can be collected by the patient on the smart device. That information can be uploaded to the web database server and viewed via web browser connection. The patient may also view prescription information entered by a healthcare professional on the central web database server.
The invention will be described more in detail with reference to the following drawings.
The use of a smart device communicating using BLUETOOTH® with the external electronics box 130 is only one embodiment of the present invention. Alternatively other wireless means or even a wired connection may be used. In another embodiment, the output of the external electronics box 130 is processed using Lab VIEW or custom application running on a notebook or desktop computer with connection either wireless or wired.
The device may be used at home, work, physician's office, clinic, nursing home, pelvic health or other center or other locations suitable for the patient. A physician, nurse, technician, physical therapist, or central customer support may supply support for the patient. Central customer support may be provided even on a 24 hour, seven-day a week basis.
A cross section of the vaginal device 600 looking from the end from which cable 610 comes out is shown in
The vaginal device was designed with manufacturability as a key consideration. A critical element is that molding the silicone with the electronics enclosed takes too long a time to cure because the electronics used have a maximum temperature of 65° C. Short enough curing time to make such molding commercially practical requires the liquid silicone to be heated to on the order of 175° C. One manufacturing approach therefore was to mold upper cylinder half 630, lower cylinder half 640, and silicone sheath 620 at the higher temperature. The flexible electronics strip may then be placed on an upside-down upper cylinder half 630 with the MEMS accelerometers fitting into pockets in its surface placed by the mold tooling. The upside-down lower cylinder 640 may be coated with adhesive and then placed over the upside-down upper cylinder 630 tooling. Once the whole cylinder is assembled, the silicone sheath 620 may be placed into a fixture that applies vacuum to its sides and enlarges the opening. The full cylinder containing the sandwiched flexible electronics strip may then be inserted into the opening of the silicone sheath until the end of the full cylinder hits the end of sheath 620. The vacuum may then be released and the cylinder is suitably enclosed within the sheath. The wall of sheath 620 may be longer than the length of the cylinder. This is done so there will be a pocket surrounding cable 610 that when filled in with silicone material (Dow Silastic) that adheres to the silicone cylinder, the silicone sheath and the cable. All of the silicone materials are biocompatible. The cable jacket may be biocompatible or coated with a layer of Parylene or other coating that is biocompatible.
External electronics box 700 in
When a session is closed, the data may be kept both in a file on the smart device uploaded to a database on the central database server. The user does not need to take any action for the latter to happen. If the smart device does not have an Internet connection at the time a given session is closed, the data for that session may be uploaded at a later time when both the application is being used and an Internet connection is available. Those with access authorization may access the data in the database. Such users may be the patient, the healthcare provide taking care of them, third party payers, or central customer support personnel in some circumstances. The patient must give authorization for the various uses of the information. The patient may view her history on the smart device or on a web browser. The healthcare professional via a web browser may provide a prescription for the patient (e.g., how many sessions per day and length of each session) placed in the central database. The patient using a web browser may access that prescription. In another embodiment, the patient may keep a diary on the smart device and that diary information is uploaded to the central database and accessible by the patient and authorized healthcare professionals.
The invention supports the patient. The process begins with a healthcare professional training the patient in the use of the LEVA® device. The patient may receive feedback from the LEVA® device on how well she is doing her Kegel exercises. Proper performance of the Kegel exercises may provide for prevention or mitigation of pelvic dysfunction including urinary incontinence, fecal incontinence, pelvic pain, and pelvic-organ prolapse. Proper performance of Kegels may also result in improvement of sexual experience. With permission of the patient, data from the sessions may be shared with the healthcare professional(s) taking care of the patient either through the web-based database or by the patient bringing in their LEVA® device. For third-party payments, the web-based database data may be available to authorized third parties.
The various embodiments described above are provided by way of illustration only and should not be construed to limit the invention. Based on the above discussion and illustrations, those skilled in the art will readily recognize that various modifications and changes may be made to the present invention without strictly following the exemplary embodiments and applications illustrated and described herein. Such modifications and changes do not depart from the true spirit and scope of the present invention.
This Application is a National Stage Application of PCT/US2015/10356, filed Jan. 6, 2015, which is related to and claims priority benefit of U.S. Application No. 61/923,997, filed Jan. 6, 2014, each of which are incorporated fully herein by reference for all purposes.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2015/010356 | 1/6/2015 | WO |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2015/103629 | 7/9/2015 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
3854476 | Dickinson, III et al. | Dec 1974 | A |
2830582 | Ljung | May 1987 | A |
4669478 | Robertson | Jun 1987 | A |
D309866 | Fukuda et al. | Aug 1990 | S |
D310275 | Su | Aug 1990 | S |
5328077 | Lou | Jul 1994 | A |
5386836 | Biswas | Feb 1995 | A |
5406961 | Artal | Apr 1995 | A |
5562717 | Tippey | Oct 1996 | A |
5603685 | Tutrone, Jr. | Feb 1997 | A |
5674238 | Sample | Oct 1997 | A |
5924984 | Rao | Jul 1999 | A |
6001060 | Churchill et al. | Dec 1999 | A |
6021781 | Thompson | Feb 2000 | A |
6039701 | Sliwa et al. | Mar 2000 | A |
6056699 | Sohn et al. | May 2000 | A |
6080118 | Blythe | Jun 2000 | A |
6086549 | Neese | Jul 2000 | A |
6264582 | Remes | Jul 2001 | B1 |
6272371 | Shlomo | Aug 2001 | B1 |
D458681 | Sherlock et al. | Jun 2002 | S |
6413206 | Biswas | Jul 2002 | B2 |
6432037 | Eini et al. | Aug 2002 | B1 |
6511427 | Sliwa, Jr. et al. | Jan 2003 | B1 |
6672996 | Ross et al. | Jan 2004 | B2 |
6679854 | Honda et al. | Jan 2004 | B2 |
6741895 | Gafni et al. | May 2004 | B1 |
D491079 | Lim | Jun 2004 | S |
D491274 | Dubniczki et al. | Jun 2004 | S |
6816744 | Garfield et al. | Nov 2004 | B2 |
7079882 | Schmidt | Jul 2006 | B1 |
7104950 | Levy | Sep 2006 | B2 |
D535203 | Chen | Jan 2007 | S |
D548359 | Illein et al. | Aug 2007 | S |
7577476 | Hochman et al. | Aug 2009 | B2 |
7608037 | Levy | Oct 2009 | B2 |
7628744 | Hoffman et al. | Dec 2009 | B2 |
7645220 | Hoffman et al. | Jan 2010 | B2 |
7736298 | Guerquin et al. | Jun 2010 | B2 |
7837682 | Ostrovsky et al. | Nov 2010 | B2 |
7892179 | Rieth | Feb 2011 | B2 |
7955241 | Hoffman et al. | Jun 2011 | B2 |
7957794 | Hochman et al. | Jun 2011 | B2 |
D651531 | Rothman | Jan 2012 | S |
8147429 | Mittal et al. | Apr 2012 | B2 |
8360954 | Kim | Jan 2013 | B2 |
8623004 | Johnson et al. | Jan 2014 | B2 |
8715204 | Webster et al. | May 2014 | B2 |
8728140 | Feemster et al. | May 2014 | B2 |
8740767 | Rosen et al. | Jun 2014 | B2 |
8805472 | Iglesias | Aug 2014 | B2 |
8821407 | Kirsner | Sep 2014 | B2 |
8914111 | Haessler et al. | Dec 2014 | B2 |
8983627 | Pelger et al. | Mar 2015 | B2 |
9155885 | Wei et al. | Oct 2015 | B2 |
D759813 | Newman et al. | Jun 2016 | S |
D759814 | Newman et al. | Jun 2016 | S |
9381351 | Haessler | Jul 2016 | B2 |
9408685 | Hou et al. | Aug 2016 | B2 |
9861316 | Egorov | Jan 2018 | B2 |
9970923 | Sturman et al. | May 2018 | B2 |
9974635 | Rosen et al. | May 2018 | B2 |
D832437 | Zeltwanger et al. | Oct 2018 | S |
D841155 | McMenamin et al. | Feb 2019 | S |
D845478 | Luke | Apr 2019 | S |
D846120 | Wallis et al. | Apr 2019 | S |
D852069 | Fu | Jun 2019 | S |
D853035 | Moretti | Jul 2019 | S |
D855825 | Parsons et al. | Aug 2019 | S |
10470862 | Iglesias | Nov 2019 | B2 |
D888949 | Beer et al. | Jun 2020 | S |
D889649 | Beer et al. | Jul 2020 | S |
D893026 | Leather | Aug 2020 | S |
D896958 | Beer et al. | Sep 2020 | S |
D896959 | Beer et al. | Sep 2020 | S |
D897530 | Beer et al. | Sep 2020 | S |
D898911 | Beer et al. | Oct 2020 | S |
D899593 | Beer et al. | Oct 2020 | S |
D903853 | Wiegerinck | Dec 2020 | S |
D903896 | Tianhao et al. | Dec 2020 | S |
D908160 | Sun | Jan 2021 | S |
D909679 | Chen | Feb 2021 | S |
D910851 | Lagrange et al. | Feb 2021 | S |
D918390 | Ollivier | May 2021 | S |
D919083 | Lee | May 2021 | S |
D923806 | Bunger von Wurmb et al. | Jun 2021 | S |
D923876 | Hasegawa | Jun 2021 | S |
11135085 | Mikkonen et al. | Oct 2021 | B2 |
20010001125 | Schulman et al. | May 2001 | A1 |
20020022836 | Goble et al. | Feb 2002 | A1 |
20020111586 | Mosel et al. | Aug 2002 | A1 |
20030028180 | Franco | Feb 2003 | A1 |
20040236223 | Barnes et al. | Nov 2004 | A1 |
20040260207 | Eini et al. | Dec 2004 | A1 |
20050148447 | Nady | Jul 2005 | A1 |
20050177067 | Tracey et al. | Aug 2005 | A1 |
20050256423 | Kirsner | Nov 2005 | A1 |
20060036188 | Hoffman et al. | Feb 2006 | A1 |
20060074289 | Adler et al. | Apr 2006 | A1 |
20060084848 | Mitchnick | Apr 2006 | A1 |
20060211911 | Jao et al. | Sep 2006 | A1 |
20070066880 | Lee et al. | Mar 2007 | A1 |
20070232882 | Glossop et al. | Oct 2007 | A1 |
20070255090 | Addington et al. | Nov 2007 | A1 |
20070265675 | Lund et al. | Nov 2007 | A1 |
20070270686 | Ritter et al. | Nov 2007 | A1 |
20080077053 | Epstein et al. | Mar 2008 | A1 |
20080139876 | Kim | Jun 2008 | A1 |
20080146941 | Dala-Krishna | Jun 2008 | A1 |
20080149109 | Ziv | Jun 2008 | A1 |
20080154131 | Lee et al. | Jun 2008 | A1 |
20080171950 | Franco | Jul 2008 | A1 |
20080300658 | Meskens | Dec 2008 | A1 |
20090024001 | Parks | Jan 2009 | A1 |
20090149740 | Hoheisel | Jun 2009 | A1 |
20090216071 | Zipper | Aug 2009 | A1 |
20090270963 | Pelger et al. | Oct 2009 | A1 |
20090306509 | Pedersen et al. | Dec 2009 | A1 |
20100069784 | Blaivas | Mar 2010 | A1 |
20100174218 | Shim | Jul 2010 | A1 |
20100222708 | Hitchcock et al. | Sep 2010 | A1 |
20100249576 | Askarinya et al. | Sep 2010 | A1 |
20100262049 | Novak et al. | Oct 2010 | A1 |
20110054357 | Egorov et al. | Mar 2011 | A1 |
20110077500 | Shakiba | Mar 2011 | A1 |
20110144458 | Gauta | Jun 2011 | A1 |
20110190580 | Bennett | Aug 2011 | A1 |
20110190595 | Bennett | Aug 2011 | A1 |
20110196263 | Egorov et al. | Aug 2011 | A1 |
20120016258 | Webster et al. | Jan 2012 | A1 |
20120245490 | Fausett | Sep 2012 | A1 |
20120265044 | Broens | Oct 2012 | A1 |
20120265049 | Iglesias | Oct 2012 | A1 |
20130035611 | White | Feb 2013 | A1 |
20130053627 | Bercovich et al. | Feb 2013 | A1 |
20130130871 | McCoy | May 2013 | A1 |
20130144191 | Egorov et al. | Jun 2013 | A1 |
20130184567 | Xie | Jul 2013 | A1 |
20130192606 | Ziv et al. | Aug 2013 | A1 |
20130237771 | Runkewitz et al. | Sep 2013 | A1 |
20130324380 | Horsley | Dec 2013 | A1 |
20140066813 | Daly et al. | Mar 2014 | A1 |
20140073879 | Cantor et al. | Mar 2014 | A1 |
20140088471 | Leivseth | Mar 2014 | A1 |
20140155225 | Sedic | Jun 2014 | A1 |
20140213927 | Webster et al. | Jul 2014 | A1 |
20140296705 | Iglesias | Oct 2014 | A1 |
20140309550 | Iglesias | Oct 2014 | A1 |
20150032030 | Iglesias | Jan 2015 | A1 |
20150112230 | Iglesias | Apr 2015 | A1 |
20150112231 | Iglesias | Apr 2015 | A1 |
20150133832 | Courtion et al. | May 2015 | A1 |
20150196802 | Siegel | Jul 2015 | A1 |
20150282763 | Rosenshein | Oct 2015 | A1 |
20160008664 | Siegel | Jan 2016 | A1 |
20160022198 | De Laat | Jan 2016 | A1 |
20160051354 | Patankar et al. | Feb 2016 | A1 |
20160074276 | Scheuring et al. | Mar 2016 | A1 |
20160121105 | Lee et al. | May 2016 | A1 |
20160279469 | Rose | Sep 2016 | A1 |
20160346610 | Iglesias et al. | Dec 2016 | A1 |
20170281072 | Iglesias | Oct 2017 | A1 |
20170281299 | Iglesias | Oct 2017 | A1 |
20170291012 | Iglesias | Oct 2017 | A1 |
20170303843 | Iglesias | Oct 2017 | A1 |
20170312530 | Schilling et al. | Nov 2017 | A1 |
20170332959 | Bartlett | Nov 2017 | A1 |
20180021121 | Zeltwanger et al. | Jan 2018 | A1 |
20190133738 | Rosen et al. | May 2019 | A1 |
20190160332 | Beer et al. | May 2019 | A1 |
20200029812 | Govari et al. | Jan 2020 | A1 |
20200069161 | Schentag et al. | Mar 2020 | A1 |
20200405142 | Whitaker | Dec 2020 | A1 |
20210321983 | Miyamoto | Oct 2021 | A1 |
Number | Date | Country |
---|---|---|
2862928 | Aug 2013 | CA |
103 45 282 | Apr 2005 | DE |
2 689 724 | Jan 2014 | EP |
2689724 | Jan 2014 | EP |
3366212 | Aug 2018 | EP |
249754 | Jan 2013 | GB |
2002-143133 | May 2002 | JP |
2009-538176 | Nov 2009 | JP |
2011-183167 | Sep 2011 | JP |
2307636 | Oct 2007 | RU |
WO 9605768 | Feb 1996 | WO |
WO-9605768 | Feb 1996 | WO |
WO-9905963 | Feb 1999 | WO |
WO-0009013 | Feb 2000 | WO |
WO 0009013 | Feb 2000 | WO |
WO-0023030 | Apr 2000 | WO |
WO-0217987 | Mar 2002 | WO |
WO 2006107930 | Oct 2006 | WO |
WO-2007136266 | Nov 2007 | WO |
WO 2010131252 | Nov 2010 | WO |
WO 2011050252 | Apr 2011 | WO |
WO 2011121591 | Oct 2011 | WO |
WO 2011159906 | Dec 2011 | WO |
WO 2012079127 | Jun 2012 | WO |
2012138232 | Oct 2012 | WO |
WO 2013082006 | Jun 2013 | WO |
WO 2013116310 | Aug 2013 | WO |
WO-2013116310 | Aug 2013 | WO |
WO 2015103629 | Jul 2015 | WO |
WO 2016026914 | Feb 2016 | WO |
WO 2016042310 | Mar 2016 | WO |
WO 2016067023 | May 2016 | WO |
WO-2016119002 | Aug 2016 | WO |
WO-2016203485 | Dec 2016 | WO |
WO-2017149688 | Sep 2017 | WO |
WO-2018023037 | Feb 2018 | WO |
WO-2019084468 | May 2019 | WO |
WO-2019084469 | May 2019 | WO |
WO-2020092343 | May 2020 | WO |
Entry |
---|
US 9,248,265 B2, 02/2016, Haessler (withdrawn) |
International Search Report and Written Opinion, dated Mar. 26, 2015, issued in International Application No. PCT/US2015/010356, filed on Jan. 6, 2015. |
Extended European Search Report dated Aug. 16, 2017 issued in related EP Application No. 15733078.8. filed Aug. 2, 2016. |
Rosenbaum, Talli Y. et al., “The Role of Pelvic Floor Physical Therapy in the Treatment of Pelvic and Genital Pain-Related Sexual Dysfunction”, 2008, J. Sex Med, 5: pp. 513-523. |
Glazer et al., “Pelvic floor muscle biofeedback in the treatment of urinary incontinence: A literature review.”, Applied Psychophysiology and Biofeedback 31(3): 187-201 (2006). |
Parekh et al., “The role of pelvic floor exercises on post-prostatectomy incontinence,” J Urol. 170(1):130-33 (2003) (Abstract Only) (2 pages). |
Moen et al., “Pelvic floor muscle function in women presenting with pelvic floor disorders,” Int Urogynecol J Pelvic Floor Dysfunct. 20(7):843-6 (2009). |
Kandadai et al., “Correct Performance of Pelvic Muscle Exercises in Women Reporting Prior Knowledge,” Female Pelvic Med Reconstr Surg. 21(3):135-40 (2015). |
Rosenblatt et al., “Interactive Pelvic Floor Muscle Training for Female Urinary Incontinence,” Renovia, Inc., retrieved Apr. 30, 2019 from <https://renoviainc.com/wp-content/uploads/2018/04/REN005.01-White-Paper-12Apr18-FINAL.pdf> (2018) (6 pages). |
Malcovati et al., Interface Circuitry and Microsystems. MEMS˜A Practical Guide to Design, Analysis, and Applications. Jan G. Korvink and Oliver Paul, 901-942 (2006). |
Rosenbaum et al., “The Role of Pelvic Floor Pysical Therapy in the Treatment of Pelvic and Genital Pain-Related Sexual Dysfunction,” J Sex Med. 5(3): 513-23 (2008). |
Rosenblatt et al., “Evaluation of an accelerometer-based digital health system for the treatment of female urinary incontinence: A pilot study,” Neurourol Urodyn. 38(7): 1944-1952 (2019). |
Nygaard et al., “Efficacy of pelvic floor muscle exercises in women with stress, urge, and mixed urinary incontinence,” Am J Obstet Gynecol. 174(1 Pt 1):120-125 (1996) (Abstract only). |
International Search Report and Written Opinion for International Application No. PCT/US2019/058527, dated Feb. 21, 2020 (18 pages). |
Office Action for Japanese Patent Application No. 2019-504938, dated May 18, 2021 (10 pages). |
International Search Report and Written Opinion for International Application No. PCT/US2021/033155, dated Aug. 25, 2021 (19 pages). |
Communication pursuant to Article 94(3) EPC for European Patent Application No. 15733078.8, dated Aug. 24, 2021 (8 pages). |
Office Action for Japanese Patent Application No. 2020-143711, dated Sep. 8, 2021 (4 pages). |
First Examination Report for Australian Patent Application No. 2020281099, dated Nov. 2, 2021 (6 pages). |
Office Action for Brazilian Patent Application No. BR112019001746-1, dated Dec. 10, 2021 (5 pages). |
Extended European Search Report for European Patent Application No. 19793343.5, dated Jan. 27, 2022 (7 pages). |
Notice of Preliminary Rejection for Korean Patent Application No. 10-2019-7005863, dated Jan. 26, 2022 (17 pages). |
Office Action for Chinese Patent Application No. 201780060078.4, dated Jan. 17, 2022 (20 pages). |
Office Action for Japanese Patent Application No. 2019-504938, dated Feb. 8, 2022 (13 pages). |
Office Action for Chinese Patent Application No. 201880083895.6, dated Feb. 8, 2022 (24 pages). |
Number | Date | Country | |
---|---|---|---|
20160346610 A1 | Dec 2016 | US |
Number | Date | Country | |
---|---|---|---|
61923997 | Jan 2014 | US |